跳至主要内容
临床试验/IRCT20170123032145N4
IRCT20170123032145N4招募中未知

The Efficacy of Memantine as Adjunctive Therapy in Obsessive Compulsive Disorder A Double blind Placebo controlled Randomized Trial

Iran University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients who meet DSM-5 criterion for OCD and they achieve more than 21 for Yale-Brown Obsessive Compulsive Scale are suitable for study.
  • They should be 18-65 year old
  • and sign consent form

排除标准

  • They should not be treated by any psychiatric interventions for last 6 weeks.
  • If they show any other important mental condition or suicidal thought, neurological deficit, will exclude from study.
  • They will be evaluated for cardiac, liver, kidney, pregnancy, lactation and mental retardation before entrance and any mentioned conditions will cause exclusion from study.

研究者

相似试验

Memantine for treatment of Obsessive-Compulsive... | 临床试验